10-Sep-2026
No headlines found.
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
Globe Newswire (Thu, 6-Aug 7:00 AM ET)
Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
Globe Newswire (Wed, 1-Jul 7:00 AM ET)
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
Globe Newswire (Mon, 22-Jun 8:30 AM ET)
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Foghorn Therapeutics trades on the NASDAQ stock market under the symbol FHTX.
As of September 10, 2026, FHTX stock price declined to $4.49 with 383,434 million shares trading.
FHTX has a beta of 2.24, meaning it tends to be more sensitive to market movements. FHTX has a correlation of 0.13 to the broad based SPY ETF.
FHTX has a market cap of $266.64 million. This is considered a Small Cap stock.
Last quarter Foghorn Therapeutics reported $16 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.13.
In the last 3 years, FHTX traded as high as $10.25 and as low as $2.70.
The top ETF exchange traded funds that FHTX belongs to (by Net Assets): VTI, VXF, IWO, IBB, VTWO.
FHTX has underperformed the market in the last year with a price return of -17.3% while the SPY ETF gained +17.7%. However, in the short term, FHTX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +16.0% vs +3.1% return in SPY. But in the last 2 weeks, FHTX shares have been beat by the market, returning -32.9% compared to an SPY return of -1.1%.
FHTX support price is $4.43 and resistance is $4.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FHTX shares will trade within this expected range on the day.
